M. Malek

985 total citations
49 papers, 747 citations indexed

About

M. Malek is a scholar working on Economics and Econometrics, Strategy and Management and Management Science and Operations Research. According to data from OpenAlex, M. Malek has authored 49 papers receiving a total of 747 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Economics and Econometrics, 8 papers in Strategy and Management and 8 papers in Management Science and Operations Research. Recurrent topics in M. Malek's work include Health Systems, Economic Evaluations, Quality of Life (7 papers), Construction Project Management and Performance (7 papers) and Public-Private Partnership Projects (6 papers). M. Malek is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (7 papers), Construction Project Management and Performance (7 papers) and Public-Private Partnership Projects (6 papers). M. Malek collaborates with scholars based in United Kingdom, India and France. M. Malek's co-authors include Peter Davey, William B. Lynch, Denis Lebrun, D.J. Byrne, Sébastien Coëtmellec, D. Allano, M. Tavakoli, John Goddard, A. Cuschieri and Ali Mustapha Benkouider and has published in prestigious journals such as Nature Medicine, SHILAP Revista de lepidopterología and The Economic Journal.

In The Last Decade

M. Malek

43 papers receiving 692 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Malek United Kingdom 16 154 124 111 80 79 49 747
A. Davis United States 16 89 0.6× 49 0.4× 144 1.3× 110 1.4× 181 2.3× 53 1.2k
Yanqing Fan China 10 146 0.9× 30 0.2× 46 0.4× 308 3.9× 40 0.5× 16 3.4k
Heshui Shi China 10 149 1.0× 16 0.1× 50 0.5× 286 3.6× 42 0.5× 25 3.3k
Nanchuan Jiang China 7 130 0.8× 15 0.1× 53 0.5× 251 3.1× 42 0.5× 16 2.9k
Lingjun Ying China 4 141 0.9× 13 0.1× 66 0.6× 312 3.9× 59 0.7× 8 3.7k
Michael D. Repplinger United States 16 193 1.3× 27 0.2× 18 0.2× 89 1.1× 59 0.7× 56 692
Tim Stephens United Kingdom 14 109 0.7× 35 0.3× 35 0.3× 59 0.7× 105 1.3× 57 635
Meng Jiang China 9 78 0.5× 4 0.0× 116 1.0× 82 1.0× 77 1.0× 16 1.4k
Biju Soman India 11 22 0.1× 7 0.1× 33 0.3× 103 1.3× 79 1.0× 52 674
Mohsin Ali United States 15 177 1.1× 28 0.2× 105 0.9× 161 2.0× 37 0.5× 49 1.6k

Countries citing papers authored by M. Malek

Since Specialization
Citations

This map shows the geographic impact of M. Malek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Malek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Malek more than expected).

Fields of papers citing papers by M. Malek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Malek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Malek. The network helps show where M. Malek may publish in the future.

Co-authorship network of co-authors of M. Malek

This figure shows the co-authorship network connecting the top 25 collaborators of M. Malek. A scholar is included among the top collaborators of M. Malek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Malek. M. Malek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Malek, M., et al.. (2025). Navigating the road to success: unravelling the key factors influencing PPP selection in Indian road projects. International Journal of Indian Culture and Business Management. 34(3). 345–364.
2.
Malek, M., et al.. (2025). A bibliometric and scientometric approach-based review of Indian cultural and environmental indicators influencing health and safety in construction industry. International Journal of Indian Culture and Business Management. 34(2). 184–203.
3.
Khademi, Reza, et al.. (2024). Androgen deprivation therapy use and the risk of heart failure in patients with prostate cancer: a systematic review and meta-analysis. BMC Cardiovascular Disorders. 24(1). 756–756. 3 indexed citations
4.
Malek, M., et al.. (2023). The attraction of public-private partnerships for road construction in India, as affected by both positive and negative factors. SHILAP Revista de lepidopterología. 8(3). 165–176. 2 indexed citations
5.
Malek, M., et al.. (2023). The construction industry's health and safety factors: Identification and categorization. Management Science Letters. 14(1). 1–14. 1 indexed citations
6.
Malek, M., et al.. (2023). Health and safety management in Indian construction sector: a legal perspective. 9(4). 331–341. 1 indexed citations
8.
Wong, Kenneth, Samuel Yeung Shan Wong, Yüksel Ersoy, et al.. (2006). Effect of Social Deprivation on Mortality and the Duration of Hospital Stay after a Stroke. Cerebrovascular Diseases. 22(4). 251–257. 12 indexed citations
9.
Tavakoli, Manouche & M. Malek. (2001). The cost utility analysis of riluzole for the treatment of amyotrophic lateral sclerosis in the UK. Journal of the Neurological Sciences. 191(1-2). 95–102. 13 indexed citations
10.
Malek, M., et al.. (1999). A COST MINIMISATION ANALYSIS OF CARDIAC FAILURE TREATMENT IN THE UK USING CIBIS TRIAL DATA. International Journal of Clinical Practice. 53(1). 19–23. 9 indexed citations
11.
Tavakoli, M., Huw Davies, & M. Malek. (1999). Modelling production and cost efficiency within health care systems. Health Care Management Science. 2(2). 1–3. 1 indexed citations
12.
Malek, M., et al.. (1998). H2‐antagonist maintenance therapy versus Helicobacter pylori eradication in patients with chronic duodenal ulcer disease: a prospective study. Alimentary Pharmacology & Therapeutics. 12(9). 873–880. 15 indexed citations
13.
Bax, Richard, Roy M. Anderson, Jeremy Crew, et al.. (1998). Antibiotic resistance - what can we do?. Nature Medicine. 4(5). 545–546. 67 indexed citations
14.
Malek, M., et al.. (1996). Fluconazole versus oral polyenes in the prophylaxis of immunocompromised patients: a cost-minimization analysis. Journal of Hospital Infection. 33(1). 35–48. 9 indexed citations
15.
Davey, Peter, et al.. (1995). Prospective audit of costs and outcome of aminoglycoside treatment and of therapy for Gram-negative bacteraemia. Journal of Antimicrobial Chemotherapy. 36(3). 561–575. 14 indexed citations
16.
Davey, Peter & M. Malek. (1994). Defining Criteria for the Pharmacoeconomic Evaluation of New Oral Cephalosporins. PharmacoEconomics. 5(Supplement 2). 11–19. 11 indexed citations
17.
Byrne, D.J., et al.. (1994). Wound infection rates: the importance of definition and post-discharge wound surveillance. Journal of Hospital Infection. 26(1). 37–43. 67 indexed citations
18.
Lynch, William B., et al.. (1992). Cost-effectiveness analysis of the use of chlorhexidine detergent in preoperative whole-body disinfection in wound infection prophylaxis. Journal of Hospital Infection. 21(3). 179–191. 56 indexed citations
19.
Malek, M., William J. Lynch, A. J. Bint, et al.. (1992). A comparison of the costs of ceftazidime therapy and gentamicin combinations in three UK hospitals. Journal of Antimicrobial Chemotherapy. 29(2). 207–217. 16 indexed citations
20.
Davey, Peter, et al.. (1991). Human and non-financial costs of hospital-acquired infection. Journal of Hospital Infection. 18. 79–84. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026